Cure Today2 小时
Breaking Down the FDA Labeling Update of Xeloda and 5-FU in Cancer Care
The FDA has updated the product labeling for Xeloda and 5-FU to highlight the risks associated with dihydropyrimidine ...
Cure Today5 小时
An Expert Breaks Down What DPD Is and Labeling Updates From The FDA
Dr. Gabriel A. Brooks discusses the recent FDA product labeling update for Xeloda and 5-FU which aims to highlight risks associated with DPD deficiency.
Breast cancer treatment approved for NHS use
Six new drugs, including a treatment for patients with advanced breast cancer, have been approved for use by the NHS in ...
Scots health chiefs approve new cancer drugs for use on NHS
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
The Scientist13 小时
Syncing Cancer Therapy with the Menstrual Cycle May Boost Outcomes
Chemotherapy for breast cancer may be more effective during specific stages of the menstrual cycle, according to data from ...
Endocrinology Advisor19 小时
Enhertu Approved for HR+, HER2-Low/Ultralow Metastatic Breast Cancer
Enhertu (fam-trastuzumab deruxtecan-nxki) has received FDA approval for HR-positive, HER2-low, HER2-ultralow metastatic breast cancer.